Doudna on “The Promise and Peril of Gene Editing”

IGI Executive Director and UC Berkeley geneticist Jennifer Doudna spoke recently with Wall Street Journal’s Alexandra Wolfe about the potential of using CRISPR-Cas9 technology to develop cures for genetic diseases, as well as the important ethical implications of using such a technology in humans.

Jennifer Doudna: The Promise and Peril of Gene Editing
Wall Street Journal | Alexandra Wolfe | March 11, 2016